Cytarabine 100mg Injection

Cytarabine 100mg Injection is a prescription antimetabolite chemotherapy medicine widely used in the treatment of acute leukemias, particularly acute myelogenous leukemia (AML). This injectable anticancer product plays a crucial role in induction and consolidation therapy, helping oncologists effectively manage rapidly progressing blood cancers in controlled clinical environments.

The active ingredient, cytarabine, works by inhibiting DNA synthesis in rapidly dividing cancer cells, which disrupts their ability to multiply and survive. By targeting abnormal cell growth at the molecular level, Cytarabine Injection helps slow disease progression and supports improved treatment outcomes when used as part of combination chemotherapy regimens.

Cytarabine 100 mg Injection is administered intravenously or subcutaneously under strict medical supervision in hospitals and oncology clinics. This prescription-only product is used according to standardized treatment protocols to ensure consistent therapeutic effectiveness, safety, and reliability for patients undergoing intensive leukemia treatment.

Product Features

• Potent anticancer chemotherapy injection
• Contains Cytarabine 100 mg
• Used in leukemia and blood cancer treatment
• Antimetabolite (pyrimidine analog)
• Sterile injectable formulation
• Suitable for intravenous or subcutaneous use (as prescribed)
• Manufactured under GMP-compliant quality standards
• Prescription-required hospital medicine

How It Helps

• Inhibits DNA synthesis in rapidly dividing cancer cells
• Helps slow or stop the growth of leukemia cells
• Supports effective treatment of acute leukemias, including AML
• Enhances treatment outcomes when used in combination with chemotherapy